AVITA MEDICAL DL-0001
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more
AVITA MEDICAL DL-0001 (51KA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, AVITA MEDICAL DL-0001 (51KA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
AVITA MEDICAL DL-0001 - Net Assets Trend (None–None)
This chart illustrates how AVITA MEDICAL DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AVITA MEDICAL DL-0001 (None–None)
The table below shows the annual net assets of AVITA MEDICAL DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to AVITA MEDICAL DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
AVITA MEDICAL DL-0001 Competitors by Market Cap
The table below lists competitors of AVITA MEDICAL DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Seah Steel Corp
KO:003030
|
$168.76 Million |
|
Yantai Ishikawa Sealing Technology Co.Ltd.
SHE:301020
|
$168.83 Million |
|
Shenzhen Wenke Landscape Co Ltd
SHE:002775
|
$168.83 Million |
|
Guangdong Modern High Tech Fiber Co
SHE:300876
|
$168.89 Million |
|
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
|
$168.72 Million |
|
Ocean Plastics Co Ltd
TW:1321
|
$168.69 Million |
|
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd
SHE:301130
|
$168.69 Million |
|
Deceuninck N.V.
LSE:0MEL
|
$168.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AVITA MEDICAL DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares AVITA MEDICAL DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently AVITA MEDICAL DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares AVITA MEDICAL DL-0001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AVITA MEDICAL DL-0001 (51KA) | €- | N/A | N/A | $168.74 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |